Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07403084 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post-market Clinical Follow-up Study of NEMOST V2

Study acronym: NEMOST V2
StatusRecruiting
PhaseNot applicable
SponsorEUROS
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
EUROS
4 trials monitored
See all monitored trials
The NEMOST spinal implant is a growth domino intended for the surgical treatment of progressive scoliosis in children. As part of post-market surveillance, EUROS is conducting a retrospective and prospective study to collect clinical and radiological data on the NEMOST growth domino. Retrospective and prospective multicenter post-market surveillance clinical study. This study is interventional, non-randomized, and uncontrolled. The primary objective of this clinical study is to monitor complications related to the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children. The secondary objective of this clinical study is to monitor the performance of the NEMOST growth domino during a 5-year postoperative follow-up in patients treated for progressive scoliosis in children. The study will include 140 patients.
Trial Details
NCT Number NCT07403084
Lead Sponsor EUROS
Conditions
(from sponsor)		 Scoliosis Neuromuscular, Scoliosis Idiopathic, Consent Forms
Enrollment 140 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov